SoftOx Solutions AS: Clarification on Placement Commission

25 Sep 2025 17:51 CEST

Reference is made to the stock exchange announcement on 25 September 2025
regarding the private placement under the financing facility with Long State
Investments Limited.

For clarity, the reference to a “placement commission on market terms” relates
to the standard transaction cost that applies when raising capital through such
facilities/underwriters. This type of commission is customary in the capital
markets and comparable to underwriting fees in larger placements. It does not
represent a special benefit to Long State but reflects the normal compensation
all underwriters receive when facilitating capital raises.

For further information, please contact:
Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87
Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165
Mail: ir@soft-ox.com

About SoftOx Solutions AS:
SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company
listed on Euronext Growth Oslo. The company is developing highly effective
pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The
technology is based on extensive research and development in partnership with
leading Nordic research institutes.

More information:
Access the news on Oslo Bors NewsWeb site